HCA Earnings & Financial Statements
HCA Healthcare, Inc.
$470.44
+$9.69(+2.10%)
68
Overall
65
Value
83
Tech
57
Quality
Market Cap
$101.85B
Volume
1.08M
52W Range
$353.99 - $556.52
Target Price
$463.04
HCA earnings and financial statements: HCA Healthcare, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
HCA Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B |
| Cost of revenue | $44.23B | $3.31B | $9.90B | $9.37B | $9.48B |
| Operating income | $11.96B | $10.55B | $12.70B | $59.35B | $57.88B |
| EBITDA | $15.65B | $13.93B | $12.76B | $61.35B | $62.55B |
| Net income | $6.78B | $5.76B | $5.24B | $5.64B | $7.72B |
| EPS (diluted) | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $60.72B | $59.51B | $56.21B | $52.44B | $50.74B |
| Total liabilities | $59.81B | $55.37B | $51.73B | $49.37B | $49.25B |
| Shareholders’ equity | -$6.03B | -$2.50B | -$1.77B | -$2.77B | -$933.00M |
| Cash and equivalents | $1.04B | $1.93B | $935.00M | $908.00M | $1.45B |
| Long-term debt | $43.46B | $40.20B | $39.07B | $39.47B | $36.10B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $12.64B | $10.51B | $9.43B | $8.52B | $8.96B |
| Capital expenditure | -$4.94B | -$4.88B | -$4.74B | -$4.39B | -$3.58B |
| Free cash flow | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B |
| Dividends paid | $679.00M | $690.00M | $661.00M | $653.00M | $624.00M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HCA | $470.44 | +2.1% | 1.08M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |